Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch.

Miro C, Di Cicco E, Ambrosio R, Mancino G, Di Girolamo D, Cicatiello AG, Sagliocchi S, Nappi A, De Stefano MA, Luongo C, Antonini D, Visconte F, Varricchio S, Ilardi G, Del Vecchio L, Staibano S, Boelen A, Blanpain C, Missero C, Salvatore D, Dentice M.

Nat Commun. 2019 Nov 27;10(1):5410. doi: 10.1038/s41467-019-13140-2.

2.

Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients.

Statuto T, Valvano L, Calice G, Villani O, Pietrantuono G, Mansueto G, D'Arena G, Vita G, Lalinga V, Possidente L, Del Vecchio L, D'Auria F, Musto P.

Leuk Res. 2019 Nov 12;88:106267. doi: 10.1016/j.leukres.2019.106267. [Epub ahead of print]

PMID:
31759282
3.

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Greene T, Ying J, Vonesh EF, Tighiouart H, Levey AS, Coresh J, Herrick JS, Imai E, Jafar TH, Maes BD, Perrone RD, Del Vecchio L, Wetzels JFM, Heerspink HJL, Inker LA.

J Am Soc Nephrol. 2019 Sep;30(9):1756-1769. doi: 10.1681/ASN.2019010009. Epub 2019 Jul 10.

PMID:
31292198
4.

RYR1 Sequence Variants in Myopathies: Expression and Functional Studies in Two Families.

Zullo A, Perrotta G, D'Angelo R, Ruggiero L, Gravino E, Del Vecchio L, Santoro L, Salvatore F, Carsana A.

Biomed Res Int. 2019 Apr 21;2019:7638946. doi: 10.1155/2019/7638946. eCollection 2019.

5.

DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation.

Trino S, Zoppoli P, Carella AM, Laurenzana I, Weisz A, Memoli D, Calice G, La Rocca F, Simeon V, Savino L, Del Vecchio L, Musto P, Caivano A, De Luca L.

Stem Cell Res Ther. 2019 May 20;10(1):138. doi: 10.1186/s13287-019-1245-6.

6.

RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.

D'Angelo D, Mussnich P, Sepe R, Raia M, Del Vecchio L, Cappabianca P, Pellecchia S, Petrosino S, Saggio S, Solari D, Fraggetta F, Fusco A.

J Mol Med (Berl). 2019 Jul;97(7):1019-1032. doi: 10.1007/s00109-019-01789-7. Epub 2019 May 10.

PMID:
31076808
7.

Will the results of the Proactive IV Iron Therapy in Haemodialysis Patients trial impact the anaemia guidelines?

Locatelli F, Del Vecchio L.

Nephrol Dial Transplant. 2019 Dec 1;34(12):1991-1993. doi: 10.1093/ndt/gfz052. No abstract available.

PMID:
30932163
8.

Features, reason for testing, and changes with time of 583 paroxysmal nocturnal hemoglobinuria clones from 529 patients: a multicenter Italian study.

Cannizzo E, Raia M, De Propris MS, Triolo A, Scarpati B, Marfia A, Stacchini A, Buccisano F, Lanza F, Regazzoli A, Michelutti A, Cesaro S, Conte CA, Vanelli L, Tedone E, Omedè P, Ciriello MM, Caporale R, Catinella V, Pantano G, De Rosa C, Lo Pardo C, Poletti G, Ulbar F, Pavanelli MC, Del Pup L, Ottaviano V, Santonocito AM, Bartocci C, Boscaro E, Arras M, Amodeo R, Mestice A, Oliva B, Ferrari L, Statuto T, D'Auria F, Pianezze G, Tanca D, Visconte F, Rubba F, Musto P, Geuna M, Gatti A, Brando B, Del Vecchio L.

Ann Hematol. 2019 May;98(5):1083-1093. doi: 10.1007/s00277-019-03644-8. Epub 2019 Mar 13.

PMID:
30868306
9.

Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?

Locatelli F, Del Vecchio L.

Nephrol Dial Transplant. 2019 Mar 7. pii: gfz031. doi: 10.1093/ndt/gfz031. [Epub ahead of print]

PMID:
30844045
10.

New agents to reduce cholesterol levels: implications for nephrologists.

Del Vecchio L, Baragetti I, Locatelli F.

Nephrol Dial Transplant. 2019 Feb 11. doi: 10.1093/ndt/gfz013. [Epub ahead of print]

PMID:
30753594
11.

Retraction: Haploinsufficiency of the Hmga1 Gene Causes Cardiac Hypertrophy and Myelo-Lymphoproliferative Disorders in Mice.

Fedele M, Fidanza V, Battista S, Pentimalli F, Klein-Szanto AJP, Visone R, De Martino I, Curcio A, Morisco C, Del Vecchio L, Baldassarre G, Arra C, Viglietto G, Indolfi C, Croce CM, Fusco A.

Cancer Res. 2018 Dec 15;78(24):6908. doi: 10.1158/0008-5472.CAN-18-3457. No abstract available.

PMID:
30552126
12.

Predictors of strut coverage of drug eluting stent implantation in diabetic patients.

Briguori C, Quintavalle C, Donahue M, D'Alessio F, D'Amore C, Signoriello G, Del Vecchio L, De Caterina R, Condorelli G.

Int J Cardiol. 2019 Feb 1;276:61-65. doi: 10.1016/j.ijcard.2018.11.025. Epub 2018 Nov 9.

PMID:
30473337
13.

Label-Free Quantitative Proteomics in a Methylmalonyl-CoA Mutase-Silenced Neuroblastoma Cell Line.

Costanzo M, Cevenini A, Marchese E, Imperlini E, Raia M, Del Vecchio L, Caterino M, Ruoppolo M.

Int J Mol Sci. 2018 Nov 13;19(11). pii: E3580. doi: 10.3390/ijms19113580.

14.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
15.

Future in the Past: Azorella glabra Wedd. as a Source of New Natural Compounds with Antiproliferative and Cytotoxic Activity on Multiple Myeloma Cells.

Lamorte D, Faraone I, Laurenzana I, Milella L, Trino S, De Luca L, Del Vecchio L, Armentano MF, Sinisgalli C, Chiummiento L, Russo D, Bisaccia F, Musto P, Caivano A.

Int J Mol Sci. 2018 Oct 26;19(11). pii: E3348. doi: 10.3390/ijms19113348.

16.

[Network references for rare diseases: state of the art for the paroxysmal nocturnal hemoglobinuria].

Alfano R, Palladino R, Risitano A, De Pascale T, Raia M, Castrianni D, Scamardo MS, Cerbone V, Schiavone D, D'Onofrio G, Buonocore G, Triassi M, Del Vecchio L, Rubba F.

Epidemiol Prev. 2018 Sep-Dec;42(5-6):333-343. doi: 10.19191/EP18.5-6.P333.102. Review. Italian.

PMID:
30370735
17.

Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.

Provenzano M, Chiodini P, Minutolo R, Zoccali C, Bellizzi V, Conte G, Locatelli F, Tripepi G, Del Vecchio L, Mallamaci F, Di Micco L, Russo D, Heerspink HJL, De Nicola L; Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.

Nephrol Dial Transplant. 2018 Jul 23. doi: 10.1093/ndt/gfy217. [Epub ahead of print]

PMID:
30053127
18.

Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies.

Laurenzana I, Lamorte D, Trino S, De Luca L, Ambrosino C, Zoppoli P, Ruggieri V, Del Vecchio L, Musto P, Caivano A, Falco G.

Stem Cells Int. 2018 May 27;2018:9863194. doi: 10.1155/2018/9863194. eCollection 2018. Review.

19.

Should we really STOP treating patients with IgA nephropathy with steroids?

Locatelli F, Del Vecchio L, Ponticelli C.

Physiol Int. 2018 Jun 1;105(2):101-109. doi: 10.1556/2060.105.2018.2.10. Review.

PMID:
29975121
20.

Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.

Del Vecchio L, Locatelli F.

Expert Opin Investig Drugs. 2018 Jul;27(7):613-621. doi: 10.1080/13543784.2018.1493455. Epub 2018 Jul 12. Review.

PMID:
29975110
21.

Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?

Locatelli F, Del Vecchio L.

Curr Opin Nephrol Hypertens. 2018 Sep;27(5):339-344. doi: 10.1097/MNH.0000000000000432. Review.

PMID:
29846220
22.

Current and potential treatment options for hyperphosphatemia.

Carfagna F, Del Vecchio L, Pontoriero G, Locatelli F.

Expert Opin Drug Saf. 2018 Jun;17(6):597-607. doi: 10.1080/14740338.2018.1476487. Epub 2018 May 21. Review.

PMID:
29783873
23.

The Long Non-Coding RNA RP5-1024C24.1 and Its Associated-Gene MPPED2 Are Down-Regulated in Human Thyroid Neoplasias and Act as Tumour Suppressors.

Sepe R, Pellecchia S, Serra P, D'Angelo D, Federico A, Raia M, Cortez Cardoso Penha R, Decaussin-Petrucci M, Del Vecchio L, Fusco A, Pallante P.

Cancers (Basel). 2018 May 18;10(5). pii: E146. doi: 10.3390/cancers10050146.

24.

Haemodialysis or haemodiafiltration: that is the question.

Locatelli F, Carfagna F, Del Vecchio L, La Milia V.

Nephrol Dial Transplant. 2018 Nov 1;33(11):1896-1904. doi: 10.1093/ndt/gfy035. Review.

PMID:
29688552
25.

CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.

D'Arena G, Vitale C, Rossi G, Coscia M, Omedè P, D'Auria F, Statuto T, Valvano L, Ciolli S, Gilestro M, Molica S, Bellesi S, Topini G, Panichi V, Autore F, Innocenti I, Musto P, Deaglio S, Laurenti L, Del Vecchio L.

Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2510. [Epub ahead of print]

PMID:
29602219
26.

MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Trino S, Lamorte D, Caivano A, Laurenzana I, Tagliaferri D, Falco G, Del Vecchio L, Musto P, De Luca L.

Int J Mol Sci. 2018 Feb 3;19(2). pii: E460. doi: 10.3390/ijms19020460. Review.

27.

Surface endoglin (CD105) expression on acute leukemia blast cells: an extensive flow cytometry study of 1002 patients.

Cosimato V, Scalia G, Raia M, Gentile L, Cerbone V, Visconte F, Statuto T, Valvano L, D'Auria F, Calice G, Graziano D, Musto P, Del Vecchio L.

Leuk Lymphoma. 2018 Sep;59(9):2242-2245. doi: 10.1080/10428194.2017.1416366. Epub 2018 Jan 15. No abstract available.

PMID:
29334284
28.

Roxadustat in the treatment of anaemia in chronic kidney disease.

Del Vecchio L, Locatelli F.

Expert Opin Investig Drugs. 2018 Jan;27(1):125-133. doi: 10.1080/13543784.2018.1417386. Epub 2017 Dec 25.

PMID:
29254377
29.

Altered Bioenergetic Profile in Umbilical Cord and Amniotic Mesenchymal Stem Cells from Newborns of Obese Women.

Iaffaldano L, Nardelli C, D'Alessio F, D'Argenio V, Nunziato M, Mauriello L, Procaccini C, Maruotti GM, Martinelli P, Matarese G, Pastore L, Del Vecchio L, Labruna G, Sacchetti L.

Stem Cells Dev. 2018 Feb 1;27(3):199-206. doi: 10.1089/scd.2017.0198. Epub 2018 Jan 3.

PMID:
29205089
30.

Role of Dicer1 in thyroid cell proliferation and differentiation.

Penha RCC, Sepe R, De Martino M, Esposito F, Pellecchia S, Raia M, Del Vecchio L, Decaussin-Petrucci M, De Vita G, Pinto LFR, Fusco A.

Cell Cycle. 2017;16(23):2282-2289. doi: 10.1080/15384101.2017.1380127. Epub 2017 Nov 9.

31.

Altered miR-193a-5p expression in children with cow's milk allergy.

D'Argenio V, Del Monaco V, Paparo L, De Palma FDE, Nocerino R, D'Alessio F, Visconte F, Discepolo V, Del Vecchio L, Salvatore F, Berni Canani R.

Allergy. 2018 Feb;73(2):379-386. doi: 10.1111/all.13299. Epub 2017 Sep 23.

PMID:
28857182
32.

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

La Rocca F, Airoldi I, Di Carlo E, Marotta P, Falco G, Simeon V, Laurenzana I, Trino S, De Luca L, Todoerti K, Villani O, Lackmann M, D'Auria F, Frassoni F, Neri A, Del Vecchio L, Musto P, Cilloni D, Caivano A.

Cell Oncol (Dordr). 2017 Oct;40(5):483-496. doi: 10.1007/s13402-017-0338-4. Epub 2017 Jul 18.

33.

Iron-based phosphate binders: a paradigm shift in the treatment of hyperphosphatemic anemic CKD patients?

Locatelli F, Del Vecchio L.

J Nephrol. 2017 Dec;30(6):755-765. doi: 10.1007/s40620-017-0421-y. Epub 2017 Jul 17. Review.

PMID:
28717990
34.

Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.

Briguori C, Quintavalle C, D'Alessio F, Donahue M, Roscigno G, De Micco F, Focaccio A, Visconti G, Del Vecchio L, Madonna R, De Caterina R, Condorelli G.

Int J Cardiol. 2017 Oct 1;244:112-118. doi: 10.1016/j.ijcard.2017.06.087. Epub 2017 Jun 27.

PMID:
28668399
35.

Do we need to distinguish exosomes from microvesicles in hematological malignancies?

Caivano A, Del Vecchio L, Musto P.

Leukemia. 2017 Sep;31(9):2009-2010. doi: 10.1038/leu.2017.205. Epub 2017 Jun 28. No abstract available.

PMID:
28656959
36.

CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.

Carotenuto A, Scalia G, Ausiello F, Moccia M, Russo CV, Saccà F, De Rosa A, Criscuolo C, Del Vecchio L, Brescia Morra V, Lanzillo R.

J Neuroimmunol. 2017 Aug 15;309:47-50. doi: 10.1016/j.jneuroim.2017.05.006. Epub 2017 May 12.

PMID:
28601287
37.

Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy.

Caivano A, La Rocca F, Laurenzana I, Trino S, De Luca L, Lamorte D, Del Vecchio L, Musto P.

Int J Mol Sci. 2017 Jun 2;18(6). pii: E1183. doi: 10.3390/ijms18061183. Review.

38.

Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.

De Luca L, Trino S, Laurenzana I, Tagliaferri D, Falco G, Grieco V, Bianchino G, Nozza F, Campia V, D'Alessio F, La Rocca F, Caivano A, Villani O, Cilloni D, Musto P, Del Vecchio L.

Cell Death Dis. 2017 Jun 1;8(6):e2849. doi: 10.1038/cddis.2017.253.

39.

Effects of Combined Strength and Sprint Training on Lean Mass, Strength, Power, and Sprint Performance in Masters Road Cyclists.

Del Vecchio L, Stanton R, Reaburn P, Macgregor C, Meerkin J, Villegas J, Korhonen MT.

J Strength Cond Res. 2019 Jan;33(1):66-79. doi: 10.1519/JSC.0000000000001960.

PMID:
28557858
40.

Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?

De Luca L, Trino S, Laurenzana I, Lamorte D, Caivano A, Del Vecchio L, Musto P.

Int J Mol Sci. 2017 May 9;18(5). pii: E1022. doi: 10.3390/ijms18051022. Review.

41.

Current and future chemical therapies for treating anaemia in chronic kidney disease.

Locatelli F, Del Vecchio L, Luise MC.

Expert Opin Pharmacother. 2017 Jun;18(8):781-788. doi: 10.1080/14656566.2017.1323872. Epub 2017 May 22. Review.

PMID:
28443351
42.

DiGeorge-like syndrome in a child with a 3p12.3 deletion involving MIR4273 gene born to a mother with gestational diabetes mellitus.

Cirillo E, Giardino G, Gallo V, Galasso G, Romano R, D'Assante R, Scalia G, Del Vecchio L, Nitsch L, Genesio R, Pignata C.

Am J Med Genet A. 2017 Jul;173(7):1913-1918. doi: 10.1002/ajmg.a.38242. Epub 2017 Apr 24.

PMID:
28436605
43.

Clinical practice guidelines on iron therapy: A critical evaluation.

Del Vecchio L, Locatelli F.

Hemodial Int. 2017 Jun;21 Suppl 1:S125-S131. doi: 10.1111/hdi.12562. Epub 2017 Apr 24. Review.

PMID:
28436206
44.

Epha3 acts as proangiogenic factor in multiple myeloma.

Caivano A, La Rocca F, Laurenzana I, Annese T, Tamma R, Famigliari U, Simeon V, Trino S, De Luca L, Villani O, Berardi S, Basile A, Vacca A, Saglio G, Del Vecchio L, Musto P, Cilloni D.

Oncotarget. 2017 May 23;8(21):34298-34309. doi: 10.18632/oncotarget.16100.

45.

POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.

Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele M.

J Biol Chem. 2017 Mar 31;292(13):5609. doi: 10.1074/jbc.A117.346270. No abstract available.

46.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
47.

Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes.

Borriello F, Iannone R, Di Somma S, Vastolo V, Petrosino G, Visconte F, Raia M, Scalia G, Loffredo S, Varricchi G, Galdiero MR, Granata F, Del Vecchio L, Portella G, Marone G.

J Immunol. 2017 May 1;198(9):3426-3435. doi: 10.4049/jimmunol.1601497. Epub 2017 Mar 24.

48.

Multicenter validation of a simplified method for paroxysmal nocturnal hemoglobinuria screening.

Gatti A, Del Vecchio L, Geuna M, Della Porta MG, Brando B.

Eur J Haematol. 2017 Jul;99(1):27-35. doi: 10.1111/ejh.12885. Epub 2017 Apr 17.

PMID:
28332730
49.

Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study.

Locatelli F, Andrulli S, Viganò SM, Concetti M, Urbini S, Giacchino F, Broccoli R, Aucella F, Cossu M, Conti P, Fattori L, Punzo G, Angelini D, Peruzzini M, Di Giulio S, Piroddi M, Galli F, Del Vecchio L.

Blood Purif. 2017;43(4):338-345. doi: 10.1159/000453442. Epub 2017 Mar 2.

50.

Nutritional Issues with Incremental Dialysis: The Role of Low-Protein Diets.

Locatelli F, Del Vecchio L, Aicardi V.

Semin Dial. 2017 May;30(3):246-250. doi: 10.1111/sdi.12585. Epub 2017 Feb 27. Review.

PMID:
28240423

Supplemental Content

Loading ...
Support Center